lactic acid has been researched along with Pulmonary Embolism in 17 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Pulmonary Embolism: Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.
Excerpt | Relevance | Reference |
---|---|---|
"The experiments test if experimental PE causes red blood cell hemolysis, arginase release and depletion of l-arginine and determine if arginase inhibition preserves l-arginine and improves pulmonary hemodynamics during PE." | 7.78 | Arginase depletes plasma l-arginine and decreases pulmonary vascular reserve during experimental pulmonary embolism. ( Das, SK; Fulkerson, MB; Gellar, MA; Kline, JA; Watts, JA, 2012) |
"The experiments test if experimental PE causes red blood cell hemolysis, arginase release and depletion of l-arginine and determine if arginase inhibition preserves l-arginine and improves pulmonary hemodynamics during PE." | 3.78 | Arginase depletes plasma l-arginine and decreases pulmonary vascular reserve during experimental pulmonary embolism. ( Das, SK; Fulkerson, MB; Gellar, MA; Kline, JA; Watts, JA, 2012) |
"After cardiac resuscitation, hypoxic encephalopathy often is the limiting factor regarding outcome due to the oxygen sensitivity of the brain." | 1.32 | Neurochemical monitoring using intracerebral microdialysis during cardiac resuscitation. ( Barbach, J; Bauer, R; Gabl, M; Galiano, K; Mohsenipour, I; Obwegeser, A, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (11.76) | 29.6817 |
2010's | 8 (47.06) | 24.3611 |
2020's | 7 (41.18) | 2.80 |
Authors | Studies |
---|---|
Varela, ML | 1 |
Mota, T | 1 |
Martins Fernandes, R | 1 |
Soto, F | 1 |
Gue, YX | 1 |
Sayers, M | 1 |
Whitby, BT | 1 |
Kanji, R | 1 |
Adatia, K | 1 |
Smith, R | 1 |
Davies, WR | 1 |
Perperoglou, A | 1 |
Potpara, TS | 1 |
Lip, GYH | 1 |
Gorog, DA | 1 |
Francis, S | 1 |
Kabrhel, C | 1 |
Parente, CS | 1 |
Sandland-Taylor, LE | 1 |
Akhtar, W | 1 |
Ebner, M | 1 |
Pagel, CF | 1 |
Sentler, C | 1 |
Harjola, VP | 1 |
Bueno, H | 1 |
Lerchbaumer, MH | 1 |
Stangl, K | 1 |
Pieske, B | 1 |
Hasenfuß, G | 1 |
Konstantinides, SV | 1 |
Lankeit, M | 1 |
Meneveau, N | 1 |
Guyther, J | 1 |
Cantwell, L | 1 |
Liedl, G | 2 |
Nazerian, P | 3 |
Pepe, G | 2 |
Caviglioli, C | 1 |
Grifoni, S | 3 |
Vanni, S | 3 |
Urbina, T | 1 |
Bigé, N | 1 |
Nguyen, Y | 1 |
Boelle, PY | 1 |
Dubée, V | 1 |
Joffre, J | 1 |
Abdallah, I | 1 |
Baudel, JL | 1 |
Maury, E | 1 |
Guidet, B | 1 |
Ait-Oufella, H | 1 |
Sathler, PC | 1 |
Lourenço, AL | 1 |
Rodrigues, CR | 1 |
da Silva, LC | 1 |
Cabral, LM | 1 |
Jordão, AK | 1 |
Cunha, AC | 1 |
Vieira, MC | 1 |
Ferreira, VF | 1 |
Carvalho-Pinto, CE | 1 |
Kang, HC | 1 |
Castro, HC | 1 |
Jiménez, D | 2 |
Morello, F | 2 |
Parisi, M | 1 |
Daghini, E | 1 |
Pratesi, M | 1 |
López, R | 1 |
Bedate, P | 1 |
Lobo, JL | 1 |
Jara-Palomares, L | 1 |
Portillo, AK | 1 |
Bova, C | 1 |
Bondi, E | 1 |
Paladini, B | 1 |
Cangioli, E | 1 |
Watts, JA | 1 |
Gellar, MA | 1 |
Fulkerson, MB | 1 |
Das, SK | 1 |
Kline, JA | 1 |
Korin, N | 1 |
Kanapathipillai, M | 1 |
Matthews, BD | 1 |
Crescente, M | 1 |
Brill, A | 1 |
Mammoto, T | 1 |
Ghosh, K | 1 |
Jurek, S | 1 |
Bencherif, SA | 1 |
Bhatta, D | 1 |
Coskun, AU | 1 |
Feldman, CL | 1 |
Wagner, DD | 1 |
Ingber, DE | 1 |
Bauer, R | 1 |
Gabl, M | 1 |
Obwegeser, A | 1 |
Galiano, K | 1 |
Barbach, J | 1 |
Mohsenipour, I | 1 |
Fadel, E | 1 |
Mazmanian, GM | 1 |
Baudet, B | 1 |
Detruit, H | 1 |
Verhoye, JP | 1 |
Cron, J | 1 |
Fattal, S | 1 |
Dartevelle, P | 1 |
Herve, P | 1 |
2 reviews available for lactic acid and Pulmonary Embolism
Article | Year |
---|---|
Current Controversies in Caring for the Critically Ill Pulmonary Embolism Patient.
Topics: Anticoagulants; Biomarkers; Computed Tomography Angiography; Critical Illness; Echocardiography; Ele | 2020 |
Big Tests in Little People.
Topics: Asthma; Biomarkers; Child; Fibrin Fibrinogen Degradation Products; Heart Diseases; Humans; Infection | 2021 |
15 other studies available for lactic acid and Pulmonary Embolism
Article | Year |
---|---|
Peeking at the right heart at the right moment: a giant thrombus in transit.
Topics: Acute-On-Chronic Liver Failure; Anticoagulants; Cardiomyopathy, Dilated; Dyspnea; Echocardiography; | 2020 |
Usefulness of the NULL-PLEASE Score to Predict Survival in Out-of-Hospital Cardiac Arrest.
Topics: Age Factors; Aged; Aged, 80 and over; Cardiopulmonary Resuscitation; Electric Countershock; Female; | 2020 |
Diagnostic challenge: an atypical presentation of infective endocarditis.
Topics: Bacteremia; Blood Culture; C-Reactive Protein; Diagnosis, Differential; Diarrhea; Dysentery; Early W | 2021 |
Venous lactate improves the prediction of in-hospital adverse outcomes in normotensive pulmonary embolism.
Topics: Hospitals; Humans; Lactic Acid; Prognosis; Prospective Studies; Pulmonary Embolism | 2021 |
Venous lactate: The new "magic marker" for stratification in intermediate-risk pulmonary embolism?
Topics: Biomarkers; Hospitals; Humans; Lactic Acid; Pulmonary Embolism; Venous Thromboembolism | 2021 |
Different time course of plasma lactate, troponin I and Nt-proBNP concentrations in patients with acute pulmonary embolism.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Female; Humans; Lactic Acid; Male; Middle Aged; Natri | 2017 |
Tissue perfusion alterations correlate with mortality in patients admitted to the intensive care unit for acute pulmonary embolism: An observational study.
Topics: Acute Disease; Aged; Aged, 80 and over; Female; Hospital Mortality; Humans; Intensive Care Units; La | 2018 |
In vitro and in vivo analysis of the antithrombotic and toxicological profile of new antiplatelets N-acylhydrazone derivatives and development of nanosystems: determination of novel NAH derivatives antiplatelet and nanotechnological approach.
Topics: Adult; Animals; Blood Coagulation; Chlorocebus aethiops; Drug Carriers; Hemolysis; Humans; Hydrazine | 2014 |
Short-term clinical outcome of normotensive patients with acute PE and high plasma lactate.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Female; Humans; Lactic Ac | 2015 |
[In Process Citation].
Topics: Critical Care; Heart Failure; Humans; Lactic Acid; Prognosis; Pulmonary Embolism; Risk Assessment; S | 2016 |
Comparison of clinical scores for identification of patients with pulmonary embolism at intermediate-high risk of adverse clinical outcome: the prognostic role of plasma lactate.
Topics: Aged; Aged, 80 and over; Biomarkers; Chi-Square Distribution; Cohort Studies; Decision Support Techn | 2017 |
Arginase depletes plasma l-arginine and decreases pulmonary vascular reserve during experimental pulmonary embolism.
Topics: Animals; Arginase; Arginine; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Enzym | 2012 |
Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels.
Topics: Animals; Biomimetic Materials; Blood Circulation; Drug Delivery Systems; Fibrinolytic Agents; Hemody | 2012 |
Neurochemical monitoring using intracerebral microdialysis during cardiac resuscitation.
Topics: Adult; Biomarkers; Brain Chemistry; Cause of Death; Cerebral Infarction; Energy Metabolism; Fatal Ou | 2004 |
Endothelial nitric oxide synthase function in pig lung after chronic pulmonary artery obstruction.
Topics: Adenosine Triphosphate; Animals; Endothelium, Vascular; Energy Metabolism; Ischemia; Lactic Acid; Lu | 2000 |